Clinical trial
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious…
NCT00333814 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00333814 |
|---|---|
| Title | A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Intermediate Uveitis, Posterior Uveitis |
| Intervention type | Drug |
| Interventions | Dexamethasone, dexamethasone, Sham injection |
| Enrollment | 229 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Jun 6, 2006 |
| Last update posted | Apr 14, 2011 |
| Countries | Australia, Austria, Brazil, Canada, Czechia, France, Germany, Greece, India, Israel, Poland, Portugal and 6 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: